A detailed history of Viewpoint Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Viewpoint Capital Management LLC holds 3,057 shares of ABBV stock, worth $514,003. This represents 0.35% of its overall portfolio holdings.

Number of Shares
3,057
Previous 3,157 3.17%
Holding current value
$514,003
Previous $489,000 13.7%
% of portfolio
0.35%
Previous 0.34%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$159.82 - $182.1 $15,982 - $18,210
-100 Reduced 3.17%
3,057 $556,000
Q2 2023

Aug 09, 2023

BUY
$132.51 - $164.9 $418,334 - $520,589
3,157 New
3,157 $425,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Viewpoint Capital Management LLC Portfolio

Follow Viewpoint Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Viewpoint Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Viewpoint Capital Management LLC with notifications on news.